Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.32 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.32 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.32 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.32 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.32 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8503703 | 0.96 | PSEN1 (0.36) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8666699 | 0.94 | NPY1R (0.33) | POLBGAANPSR1RORC | |
| SCHEMBL8479608 | 0.93 | NPY1R (0.36) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8502233 | 0.93 | GAA (0.34) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8664248 | 0.90 | PSEN1 (0.34) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8487926 | 0.88 | NPY1R (0.36) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8664324 | 0.87 | NPY1R (0.35) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8485778 | 0.85 | NPY1R (0.37) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8627056 | 0.84 | POLB (0.39) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8503794 | 0.77 | DRD2 (0.38) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5885983-A | ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-23 | — | — | US | disclosed |